If pediatric use is needed, liraglutide is currently the only option with regulatory approval for adolescents aged 12-17
Trial data showed significant drops in non-HDL cholesterol, triglycerides, and high-sensitivity C-reactive protein (a marker of cardiovascular inflammation)
In patients with comorbid coronary artery disease, obesity, and diabetes, GLP-1 agonists and SGLT-2 inhibitors should be used as first-line agents, over metformin
Review Methodology: This review is based on the official glpatch.shop product page, the brand's published FAQ, category-level published research from NCCIH, NIH-indexed studies on botanical glucose-management compounds, and peer-reviewed research on transdermal botanical delivery
The body's metabolic adaptations to weight lossincluding decreased energy expenditure, increased hunger hormones, and reduced satiety signalspersist long after weight reduction, making weight maintenance challenging without continued intervention
GLP-1 Microdose Benefits and Side Effects The biggest benefit of microdosing is comfort
